Osaic Holdings’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
Other funds holding BBC
KCP
MCM
QCM
APW
FTUS
Osaic Holdings's BBC Position: Q1 2026 in Review
Osaic Holdings reduced its Virtus Biotech Clinical Trials ETF (BBC) stake by 6.2% in Q1 2026, selling an estimated $2.05K and leaving 757 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5549.
Osaic Holdings first reported a position in BBC in Q1 2020 and has held it in 24 quarters since. The position peaked at $663K in Q2 2020. 20 funds tracked by Wall St. Rank hold BBC as of Q1 2026.
- Osaic Holdings held 757 shares of Virtus Biotech Clinical Trials ETF worth $31.5K as of Q1 2026.
- Osaic Holdings sold 50 Virtus Biotech Clinical Trials ETF shares in Q1 2026, an estimated $2.05K.
- Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5549 holding.
- Osaic Holdings first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2020 and has held it in 24 quarters since.
- Osaic Holdings's Virtus Biotech Clinical Trials ETF position peaked at $663K in Q2 2020.
- 20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.